D. Dyer, J. Dunn, S. Thorpe, K. Bailie, T. J. Lyons et al., Accumulation of Maillard reaction products in skin collagen in diabetes and aging

V. Monnier, O. Bautista, D. Kenny, D. Sell, J. Fogarty et al., Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial, Diabetes, vol.48, issue.4, pp.870-880, 1999.
DOI : 10.2337/diabetes.48.4.870

S. Genuth, W. Sun, P. Cleary, D. R. Sell, W. Dahms et al., for the DCCT Skin Collagen Ancillary Study Group Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1

D. The and . Group, The relationship of glycemic exposure (HbA1c) to the risk of development and progression in the Diabetes Control and Complications Trial, Diabetes, vol.44, pp.978-983, 1995.

R. Meerwaldt·, P. H. Graaff·, T. P. Oomen1·, J. J. Links1·, N. L. Jager· et al., Smit Simple non-invasive assessment of advanced glycation endproduct accumulation, Diabetologia, vol.47, pp.1324-1330, 2004.

R. Meerwaldt, H. Lutgers, T. Links, R. Graaff, J. Baynes et al., Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care, pp.107-119, 2007.

E. Gerrits, H. Lutgers, N. Kleefstra, R. Graaff, K. Groenier et al., Skin Autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications, Diabetes Care, vol.31, issue.3, pp.517-538, 2007.
DOI : 10.2337/dc07-1755

C. Langlois, Glycation et reaction de Maillard Chef de projet recherche Laboratoire PiLeJe http

T. Lee, M. Kimiagar, S. Pintauro, and C. Chichester, Physiological and safety aspects of Maillard browning of foods

T. Koschinsky, C. He, T. Mitsuhashi, R. Bucala, C. Liu et al., Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy, Proceedings of the National Academy of Sciences, vol.94, issue.12
DOI : 10.1073/pnas.94.12.6474

H. Vlassara and M. Palace, Diabetes and advanced glycation endproducts, Journal of Internal Medicine, vol.382, issue.2
DOI : 10.1073/pnas.95.8.4630

C. Cerami, H. Founds, I. Nicholl, T. Mitsuhashi, D. Giordano et al., Tobacco smoke is a source of toxic reactive glycation products, Proceedings of the National Academy of Sciences, vol.94, issue.25
DOI : 10.1073/pnas.94.25.13915

S. Yan, R. Ramasamy, and A. Schmidt, Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complications, Nature Clinical Practice Endocrinology & Metabolism, vol.8, issue.5
DOI : 10.1038/ncpendmet0786

J. Schmidt, A. Hori, O. Yan, and S. , Récepteurs des produits de glycation avancée et diabète sucré Sang Thrombose Vaisseaux Mini-revues 25 RAGE : a novel cellular receptor for advanced glycation end products, Diabetes, vol.9, issue.3, pp.637-678, 1996.

S. Sasaki and T. Inoguchi, The Role of Oxidative Stress in the Pathogenesis of Diabetic Vascular Complications, Diabetes & Metabolism Journal, vol.36, issue.4, pp.255-61
DOI : 10.4093/dmj.2012.36.4.255

Z. Makita, S. Radoff, and E. Rayfield, Advanced Glycosylation End Products in Patients with Diabetic Nephropathy, New England Journal of Medicine, vol.325, issue.12
DOI : 10.1056/NEJM199109193251202

J. Sun, H. Keenan, J. Cavallerano, B. Asztalos, E. Schaefer et al., Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalist Study, Diabetes Care, vol.34, issue.4, pp.968-74, 2011.
DOI : 10.2337/dc10-1675

P. Salmela, A. Oikarinen, O. Ukkola, A. Karjalainen, M. Linnaluoto et al., Improved metabolic control in patients with non-insulin-dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen, European Journal of Clinical Investigation, vol.40, issue.7
DOI : 10.2337/diacare.16.5.689

E. Schleicher, E. Wagner, and A. Nerlich, Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging., Journal of Clinical Investigation, vol.99, issue.3
DOI : 10.1172/JCI119180

R. Bernardes and J. Cunha-vaz, Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes

D. Boeri, M. Maiello, and M. Lorenzi, Increased Prevalence of Microthromboses in Retinal Capillaries of Diabetic Individuals, Diabetes, vol.50, issue.6, pp.1432-1441, 2001.
DOI : 10.2337/diabetes.50.6.1432

C. Treins, S. Giorgetti-peraldi, J. Murdaca, and E. Van-obberghen, Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products, Journal of Biological Chemistry, vol.276, issue.47
DOI : 10.1074/jbc.M106534200

P. Beisswenger, L. Moore, T. Brinck-johnsen, and T. Curphey, Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy., Journal of Clinical Investigation, vol.92, issue.1
DOI : 10.1172/JCI116552

D. Mccance, D. Dyer, I. Dunn, I. Dunn, K. Bailie et al., Baynes 1W, Lyons T Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

4. G. Wolf, Mécanismes moléculaires de l'atteinte rénale d'origine diabétique http://www.soc-nephrologie.org/PDF/enephro/publications/actualites Bendayan M Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes, 2005.

Y. Yamamoto, I. Kato, T. Doi, H. Yonekura, S. Ohashi et al., Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice, Journal of Clinical Investigation, vol.108, issue.2
DOI : 10.1172/JCI11771

N. Tanji, G. Markowitz, C. Fu, T. Kislinger, A. Taguchi et al., Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease

G. Said, Diabetic neuropathy???a review, Nature Clinical Practice Neurology, vol.326, issue.6
DOI : 10.1038/ncpneuro0504

J. Shaw and P. Zimmet, The epidemiology of diabetic neuropathy, Diabetes Rev, vol.7, pp.245-252, 1999.

A. Vinik, T. Park, K. Stansberry, G. Pittenger, and . Diabetic, Diabetic neuropathies, Diabetologia, vol.43, issue.8, pp.957-73, 2000.
DOI : 10.1007/s001250051477

S. Yagihashi, S. Yamagishi, and R. Wada, Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptoms, Diabetes Research and Clinical Practice, vol.77, issue.3
DOI : 10.1016/j.diabres.2007.01.054

M. Sinnreich, B. Taylor, and P. Dyck, Diabetic Neuropathies, The Neurologist, vol.11, issue.2, pp.63-79, 2005.
DOI : 10.1097/01.nrl.0000156314.24508.ed

I. Obrosova, Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments, Neurotherapeutics, vol.16, issue.Suppl 1, pp.638-685, 2009.
DOI : 10.1016/j.nurt.2009.07.004

S. Tesfaye and P. Kempler, Painful diabetic neuropathy. Diabetologia, pp.805-812, 2005.

J. Kennedy and D. Zochodne, Impaired peripheral nerve regeneration in diabetes mellitus, Journal of the Peripheral Nervous System, vol.19, issue.2
DOI : 10.1016/S0304-3940(97)00359-5

. Tesfayes, . Chaturvedin, . Eatonsem, . Witted, and . Wardjd, FullerJ Vascular risk factors and diabetic neuropathy

N. Karachalias, R. Babaei-jadidi, N. Ahmed, and P. Thornalley, Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats, Biochemical Society Transactions, vol.31, issue.6
DOI : 10.1042/bst0311423

C. Toth, L. Rong, C. Yang, J. Martinez, F. Song et al., Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes, pp.1002-1019, 2007.

P. Fernyhough, R. Chowdhury, S. Schmidt, and R. , Mitochondrial stress and the pathogenesis of diabetic neuropathy, Expert Review of Endocrinology & Metabolism, vol.5, issue.1, pp.39-49, 2010.
DOI : 10.1586/eem.09.55

G. Perlemuter, . Endocrinologie, A. Hirsch, M. Criqui, D. Treat-jacobson et al., nutrition collection Med Line, 4eme édition 70 Peripheral arterial disease detection, awareness, and treatment in primary care

A. Rojas, S. Romay, D. González, B. Herrera, R. Delgado et al., Regulation of Endothelial Nitric Oxide Synthase Expression by Albumin-Derived Advanced Glycosylation End Products, Circulation Research, vol.86, issue.3
DOI : 10.1161/01.RES.86.3.e50

M. Peppa, J. Uribarri, and H. Vlassara, The role of advanced glycation end products in the development of atherosclerosis, Current Diabetes Reports, vol.14, issue.suppl 1
DOI : 10.1007/s11892-004-0008-6

S. Sugiyama, T. Miyata, Y. Ueda, H. Tanaka, K. Maeda et al., Plasma levels of pentosidine in diabetic patients: an advanced glycation end product, J Am Soc Nephrol, vol.9, issue.9, pp.1681-1689, 1998.

J. Wautier and A. Schmidt, Protein Glycation: A Firm Link to Endothelial Cell Dysfunction, Circulation Research, vol.95, issue.3
DOI : 10.1161/01.RES.0000137876.28454.64

C. Dorrian, S. Cathcart, J. Clausen, D. Shapiro, and M. Dominiczak, Factors in human serum interfere with the measurement of advanced glycation endproducts

M. Koetsier, H. Lutgers, C. De-jonge, T. Links, A. Smit et al., Reference Values of Skin Autofluorescence, Diabetes Technology & Therapeutics, vol.12, issue.5, pp.399-403, 2010.
DOI : 10.1089/dia.2009.0113

C. Mast, . Boyard, . Hotto, H. Gatta-cherifi, and . Gin, Rigalleau Autofluorescence cutanée après un repas riche en produits de glycation avancée Nutrition clinique et métébolisme, pp.79-80, 2010.

A. Stirban, S. Nandrean, M. Negrean, T. Koschinsky, and D. Tschoepe, Skin Autofluorescence Increases Postprandially in Human Subjects, Diabetes Technology & Therapeutics, vol.10, issue.3, pp.200-205, 2008.
DOI : 10.1089/dia.2007.0275

E. Maury, D. Danglade, V. De-ledinghen, C. Raffaitin, H. Gin et al., P111 Autofluorescence cutan??e chez les patients cirrhotiques, Diabetes & Metabolism, vol.36, pp.1-65, 2010.
DOI : 10.1016/S1262-3636(10)70259-7

E. Gerrits, H. Lutgers, N. Kleefstra, K. Groenier, A. Smit et al., Skin Advanced Glycation End Product Accumulation is Poorly Reflected by Glycemic Control in Type 2 Diabetic Patients (ZODIAC-9), Journal of Diabetes Science and Technology, vol.51, issue.1
DOI : 10.1001/jama.295.14.1681

P. Cleary, B. Braffett, T. Orchard, T. Lyons, J. Maynard et al., Clinical and Technical Factors Associated with Skin Intrinsic Fluorescence in Subjects with Type 1 Diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study, Diabetes Technology & Therapeutics, vol.15, issue.6, pp.466-74, 2013.
DOI : 10.1089/dia.2012.0316

D. Bos, W. De-ranitz-greven, and D. Valk, Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review, Diabetes Technology & Therapeutics, vol.13, issue.7
DOI : 10.1089/dia.2011.0034

D. Bouhassira, N. Attal, H. Alchaar, F. Boureau, B. Brochet et al., Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4), Pain, vol.114, issue.1
DOI : 10.1016/j.pain.2004.12.010

H. Gin and V. , Rigalleau Dépistage de la neuropathie périphérique : quels outils ?

. Doi, DM-06, 1262.

H. Momma, K. Niu, Y. Kobayashi, L. Guan, M. Sato et al., Skin advanced glycation end product accumulation and muscle strength among adult men, European Journal of Applied Physiology, vol.44, issue.7
DOI : 10.1007/s00421-010-1779-x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114099

M. Yasuda, M. Shimura, H. Kunikata, H. Kanazawa, K. Yasuda et al., Relationship of Skin Autofluorescence to Severity of Retinopathy in Type 2 Diabetes, Current Eye Research, vol.40, issue.3, pp.1-8, 2014.
DOI : 10.2337/dc07-1755

T. Hirano, Y. Iesato, Y. Toriyama, A. Imai, D. Chiba et al., Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients, Journal of Diabetes and its Complications, vol.28, issue.5
DOI : 10.1016/j.jdiacomp.2014.03.003

M. Noordzij, D. Mulder, P. Oomen, T. Brouwer, J. Jager et al., Smit AJ Skin autofluorescence and risk of micro-and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study

R. Meerwaldt, T. Links, R. Graaff, K. Hoogenberg, J. Lefrandt et al., Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy, Diabetologia, vol.28, issue.Suppl, pp.1637-1681, 2005.
DOI : 10.1007/s00125-005-1828-x

A. Araszkiewicz, D. Naskret, P. Niedzwiecki, P. Samborski, B. Wierusz-wysocka et al., Increased Accumulation of Skin Advanced Glycation End Products Is Associated with Microvascular Complications in Type 1 Diabetes, Diabetes Technology & Therapeutics, vol.13, issue.8
DOI : 10.1089/dia.2011.0043